UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 60.

Aichmair, A; Burgstaller, J M; Schwenkglenks, Matthias; Steurer, J; Porchet, F; Brunner, F; Farshad, M; LSOS Study Group (2017). Cost-effectiveness of conservative versus surgical treatment strategies of lumbar spinal stenosis in the Swiss setting: analysis of the prospective multicenter Lumbar Stenosis Outcome Study (LSOS). European Spine Journal, 26(2):501-509.

Schmutz, C; Mäusezahl, D; Bless, P J; Hatz, C; Schwenkglenks, Matthias; Urbinello, D (2017). Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland. Epidemiology and Infection, 145(04):627-641.

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Betticher, Daniel; von Moos, Roger; Dietrich, Daniel; Baertschi, Daniela; Koeberle, Dieter (2016). Bevacizumab continuation versus treatment holidays after first-line chemotherapy with bevacizumab in patients with metastatic colorectal cancer: a health economic analysis of a randomized phase 3 trial (SAKK 41/06). Clinical Colorectal Cancer, 15(4):314-320.

Biétry, Fabienne A; Reich, Oliver; Schwenkglenks, Matthias; Meier, Christoph R (2016). Statin use and risk of cholecystectomy - A case-control analysis using Swiss claims data. Expert Opinion on Drug Safety, 15(12):1577-1582.

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Matter-Walstra, Klazien; Ruhstaller, T; Klingbiel, D; Schwenkglenks, Matthias; Dedes, K J (2016). Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK). Breast Cancer Research and Treatment, 158(1):51-57.

Kasenda, Benjamin; von Elm, Erik; You, John J; Blümle, Anette; Tomonaga, Yuki; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J; Stegert, Mihaela; Olu, Kelechi K; Tikkinen, Kari A O; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M; Mertz, Dominik; Akl, Elie A; Bassler, Dirk; Busse, Jason W; Ferreira-González, Ignacio; Lamontagne, Francois; Nordmann, Alain; Gloy, Viktoria; Raatz, Heike; Moja, Lorenzo; Ebrahim, Shanil; Schandelmaier, Stefan; Sun, Xin; Vandvik, Per O; Johnston, BC; Walter, MA; Burnand, B; Schwenkglenks, Matthias; Hemkens, LG; Bucher, HC; Guyatt, GH; Briel, M (2016). Agreements between industry and academia on publication rights: a retrospective study of protocols and publications of randomized clinical trials. PLoS Medicine, 13(6):e1002046.

Kastien-Hilka, Tanja; Abulfathi, Ahmed; Rosenkranz, Bernd; Bennett, Bryan; Schwenkglenks, Matthias; Sinanovic, Edina (2016). Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa. Health and Quality of Life Outcomes, 14(42):online.

Matter-Walstra, Klazien; Braun, R; Kolb, C; Ademi, Z; Dummer, R; Pestalozzi, B C; Schwenkglenks, Matthias (2016). Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors. British Journal of Dermatology, 174(2):463.

Schandelmaier, S; Conen, K; von Elm, E; You, J J; Blümle, A; Tomonaga, Yuki; Saccilotto, R; Amstutz, A; Bengough, T; Meerpohl, J J; Stegert, M; Olu, K K; Tikkinen, K A O; Neumann, I; Carrasco-Labra, A; Faulhaber, M; Mulla, S M; Mertz, D; Akl, E A; Sun, X; Bassler, D; Busse, J W; Ferreira-González, I; Lamontagne, F; Nordmann, A; Gloy, V; Raatz, H; Moja, L; Rosenthal, R; Ebrahim, S; Vandvik, P O; Johnston, B C; Walter, M A; Burnand, B; Schwenkglenks, Matthias; Hemkens, L G; Bucher, H C; Guyatt, G H; Briel, M; Kasenda, B; DISCO Study Group (2016). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology, 27(1):209.

Ademi, Zanfina; Gloy, Viktoria; Glinz, Dominik; Raatz, Heike; Van Stiphout, Joris; Bucher, Heiner C; Schwenkglenks, Matthias (2016). Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective. Swiss Medical Weekly, 146:w14382.

Kastien-Hilka, Tanja; Rosenkranz, Bernd; Bennett, Bryan; Sinanovic, Edina; Schwenkglenks, Matthias (2016). How to evaluate health-related quality of life and its association with medication adherence in pulmonary tuberculosis - designing a prospective observational study in South Africa. Frontiers in Pharmacology, 7:125.

Byber, Katarzyna; Flatz, Aline; Norbäck, Dan; Hitzke, Christine; Imo, David; Schwenkglenks, Matthias; Puhan, Milo A; Dressel, Holger; Mutsch, Margot (2016). Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace. Cochrane Database of Systematic Reviews, 6:CD012219.

Schwenkglenks, Matthias; Matter-Walstra, Klazien (2016). Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Review of Pharmacoeconomics & Outcomes Research, 16(2):207-219.

Schandelmaier, Stefan; von Elm, Erik; You, John J; Blümle, Anette; Tomonaga, Yuki; Lamontagne, Francois; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J; Stegert, Mihaela; Olu, Kelechi K; Tikkinen, Kari A O; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M; Mertz, Dominik; Akl, Elie A; Sun, Xin; Bassler, Dirk; Busse, Jason W; Ferreira-González, Ignacio; Nordmann, Alain; Gloy, Viktoria; Raatz, Heike; Moja, Lorenzo; Rosenthal, Rachel; Ebrahim, Shanil; Vandvik, Per O; Johnston, Bradley C; Walter, Martin A; Burnand, Bernard; Schwenkglenks, Matthias; Hemkens, Lars G; Cook, Deborah J; Meade, Maureen O; Bucher, Heiner C; Kasenda, Benjamin; Briel, Matthias (2016). Premature discontinuation of randomized trials in critical and emergency care: a retrospective cohort study. Critical Care Medicine, 44(1):130-137.

Gutzwiller, Florian S; Pfeil, Alena M; Ademi, Zanfina; Blank, Patricia R; Braunhofer, Peter G; Szucs, Thomas D; Schwenkglenks, Matthias (2015). Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. Pharmacoeconomics, 33(12):1311-1324.

Jürgens, Verena; Ess, Silvia; Schwenkglenks, Matthias; Cerny, Thomas; Vounatsou, Penelope (2015). Using lung cancer mortality to indirectly approximate smoking patterns in space. Spatial and Spatio-temporal Epidemiology, 14-15:23-31.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2015). Cancer-related therapies at the end of life in hospitalized cancer patients from four swiss cantons: SAKK 89/09. Oncology, 88(1):18-27.

Vulsteke, Christof; Pfeil, Alena M; Maggen, Charlotte; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2015). Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Research and Treatment, 152(1):67-76.

Rosenthal, Rachel; Kasenda, Benjamin; Dell-Kuster, Salome; von Elm, Erik; You, John; Blümle, Anette; Tomonaga, Yuki; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J; Stegert, Mihaela; Tikkinen, Kari A O; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail; Mertz, Dominik; Akl, Elie A; Bassler, Dirk; Busse, Jason W; Ferreira-González, Ignacio; Lamontagne, Francois; Nordmann, Alain; Gloy, Viktoria; Olu, Kelechi K; Raatz, Heike; Moja, Lorenzo; Ebrahim, Shanil; Schandelmaier, Stefan; Sun, Xin; Vandvik, Per O; Johnston, Bradley C; Walter, Martin A; Burnand, Bernard; Schwenkglenks, Matthias; Hemkens, Lars G; Bucher, Heiner C; Guyatt, Gordon H; Briel, Matthias (2015). Completion and publication rates of randomized controlled trials in surgery: an empirical study. Annals of Surgery, 262(1):68-73.

Pfeil, Alena M; Reich, Oliver; Guerra, Ines M; Cure, Sandrine; Negro, Francesco; Müllhaupt, Beat; Lavanchy, Daniel; Schwenkglenks, Matthias (2015). Cost-effectiveness analysis of Sofosbuvir compared to current standard treatment in Swiss patients with chronic Hepatitis C. PLoS ONE, 10(5):e0126984.

Blank, Patricia R; Filipits, Martin; Dubsky, Peter; Gutzwiller, Florian; Lux, Michael P; Brase, Jan C; Weber, Karsten E; Rudas, Margaretha; Greil, Richard; Loibl, Sibylle; Szucs, Thomas D; Kronenwett, Ralf; Schwenkglenks, Matthias; Gnant, Michael (2015). Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients. Pharmacoeconomics, 33(2):179-190.

Pfeil, Alena M; Allcott, Kim; Pettengell, Ruth; von Minckwitz, Gunter; Schwenkglenks, Matthias; Szabo, Zsolt (2015). Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review. Supportive Care in Cancer, 23(2):525-545.

Pfeil, Alena M; Imfeld, Patrick; Pettengell, Ruth; Jick, Susan S; Szucs, Thomas D; Meier, Christoph R; Schwenkglenks, Matthias (2015). Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD). Annals of Hematology, 94(3):421-429.

Vulsteke, Christof; Pfeil, Alena M; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Peeters, Marc; van Dam, Peter; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2014). Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Research and Treatment, 147(3):557-70.

Witassek, Fabienne; Schwenkglenks, Matthias; Erne, P; Radovanovic, Dragana (2014). Impact of body mass index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity paradox exist? Swiss Medical Weekly, 144:w13986.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons a retrospective database study (SAKK 89/09). BMC Cancer, 14:306.

Zaslansky, Ruth; Rothaug, Judith; Chapman, Richard C; Backström, Ragnar; Brill, Silviu; Engel, Christoph; Fletcher, Dominique; Fodor, Lucian; Funk, Peter; Gordon, Debra; Komann, Marcus; Konrad, Christoph; Kopf, Andreas; Leykin, Yigal; Pogatzki-Zahn, Esther; Puig, Margarita; Rawal, Narinder; Schwenkglenks, Matthias; Taylor, Rod S; Ullrich, Kristin; Volk, Thomas; Yahiaoui-Doktor, Maryam; Meissner, Winfried (2014). PAIN OUT: an international acute pain registry supporting clinicians in decision making and in quality improvement activities. Journal of Evaluation in Clinical Practice, 20(6):1090-1098.

Wieser, Simon; Tomonaga, Yuki; Riguzzi, Marco; Fischer, Barbara; Telser, Harry; Pletscher, Mark; Eichler, Klaus; Trost, Melanie; Schwenkglenks, Matthias (2014). Die Kosten der nichtübertragbaren Krankheiten in der Schweiz : Schlussbericht. Winterthur: Zürcher Hochschule für Angewandte Wissenschaften (zhaw).

Huber, Carola A; Schwenkglenks, Matthias; Rapold, Roland; Reich, Oliver (2014). Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011. BMC Endocrine Disorders, 14:44.

Matter-Walstra, Klazien; Klingbiel, Dirk; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2014). Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied? Pharmacoeconomics, 32(6):591-599.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas D; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09). BMC Cancer, 14(1):306.

Schwenkglenks, Matthias; Gerbershagen, Hans J; Taylor, Rod S; Pogatzki-Zahn, Esther; Komann, Marcus; Rothaug, Judith; Volk, Thomas; Yahiaoui-Doktor, Maryam; Zaslansky, Ruth; Brill, Silviu; Ullrich, Kristin; Gordon, Debra B; Meissner, Winfried (2014). Correlates of satisfaction with pain treatment in the acute postoperative period: Results from the international PAIN OUT registry. Pain, 155(7):1401-1411.

Jakovljevic, Mihajlo; Gutzwiller, Florian; Schwenkglenks, Matthias; Milovanovic, Olivera; Rancic, Nemanja; Varjacic, Mirjana; Stojadinovic, Dobrivoje; Dagovic, Aleksandar; Matter-Walstra, Klazien (2014). Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 19(4):1111-1120.

Huber, Carola A; Diem, Peter; Schwenkglenks, Matthias; Rapold, Roland; Reich, Oliver (2014). Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland. Diabetes, Metabolic Syndrome and Obesity, 7:455-465.

Pfeil, Alena M; Vulsteke, Christof; Paridaens, Robert; Dieudonné, Anne-Sophie; Pettengell, Ruth; Hatse, Sigrid; Neven, Patrick; Lambrechts, Diether; Szucs, Thomas D; Schwenkglenks, Matthias; Wildiers, Hans (2014). Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer, 14:201.

Krzemieniecki, K; Sevelda, P; Erdkamp, F; Smakal, M; Schwenkglenks, Matthias; Puertas, J; Trojan, A; Szabo, Z; Bendall, K; Maenpaa, J (2014). Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy-findings from clinical practice. Supportive Care in Cancer, 22(3):667-677.

Vavricka, Stephan R; Schoepfer, Alain M; Safroneeva, Ekaterina; Rogler, Gerhard; Schwenkglenks, Matthias; Achermann, Rita (2013). A shift from oral to intravenous iron supplementation therapy is observed over time in a large Swiss cohort of patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 19(4):840-846.

Bollhalder, Lea; Pfeil, Alena M; Tomonaga, Yuki; Schwenkglenks, Matthias (2013). A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clinical Nutrition, 32(2):213-223.

Jürgens, Verena; Ess, Silvia; Phuleria, Harish C; Früh, Martin; Schwenkglenks, Matthias; Frick, Harald; Cerny, Thomas; Vounatsou, Penelope (2013). Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland. Geospatial Health, 7(2):219-236.

Pettengell, Ruth; Silvestre, Antonio Salar; Schwenkglenks, Matthias; Rossi, Francesca Gaia; Duehrsen, Ulrich; Verhoef, Gregor; Lugtenburg, Pieternella Johanna; Wheeler, Tracey; Pujol, Beatriz; Haioun, Corinne (2013). Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R)CHOP. Hematology, 18(1):26-29.

Gutzwiller, Florian S; Pfeil, Alena M; Comin-Colet, Josep; Ponikowski, Piotr; Filippatos, Gerasimos; Mori, Claudio; Braunhofer, Peter G; Szucs, Thomas D; Schwenkglenks, Matthias; Anker, Stefan D (2013). Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis. International Journal of Cardiology, 168(4):3878-3883.

Schwenkglenks, Matthias; Bendall, Kate Louise; Pfeil, Alena M; Szabo, Zsolt; Pettengell, Ruth (2013). External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma, 54(11):2426-2432.

Rothaug, Judith; Zaslansky, Ruth; Schwenkglenks, Matthias; Komann, Marcus; Allvin, Renée; Backström, Ragnar; Brill, Silviu; Buchholz, Ingo; Engel, Christoph; Fletcher, Dominique; Fodor, Lucian; Funk, Peter; Gerbershagen, Hans J; Gordon, Debra B; Konrad, Christoph; Kopf, Andreas; Leykin, Yigal; Pogatzki-Zahn, Esther; Puig, Margarita; Rawal, Narinder; Taylor, Rod S; Ullrich, Kristin; Volk, Thomas; Yahiaoui-Doktor, Maryam; Meissner, Winfried (2013). Patients' perception of postoperative pain management: validation of the International Pain Outcomes (IPO) questionnaire. Journal of Pain, 14(11):1361-1370.

Blank, Patricia R; Schwenkglenks, Matthias; Sardos, Christelle Saint; Patris, Julien; Szucs, Thomas D (2013). Population access to new vaccines in European countries. Vaccine, 31(27):2862-2867.

Schwenkglenks, Matthias (2013). Stabilisierung der Gesundheitskosten in der Schweiz - ein Zwischenstand. In: Szucs, Thomas D; Künzi, Max. Brennpunkt Gesundheitssystem : 10 Jahre Schweizerischer Kongress für Gesundheitsökonomie und Gesundheitwissenschaften. Bern: Schweizerische Gesellschaft für Gesundheitspolitik, 33-36.

Taylor, Rod S; Ullrich, Kristin; Regan, Sophie; Broussard, Christina; Schwenkglenks, Matthias; Taylor, Rebecca J; Gordon, Debra B; Zaslansky, Ruth; Meissner, Winfried; Rothaug, Judith; Langford, Richard (2013). The impact of early postoperative pain on health-related quality of life. Pain Practice, 13(7):515-523.

Jürgens, Verena; Ess, Silvia; Phuleria, Harish C; Früh, Martin; Schwenkglenks, Matthias; Frick, Harald; Cerny, Thomas; Vounatsou, Penelope (2013). Tobacco-related cancer mortality: projections for different geographical regions in Switzerland. Swiss Medical Weekly, 143:w13771.

Schwenkglenks, Matthias (2013). Ökonomische Spannungsfelder im Gesundheitswesen. In: Baer, Josette; Rother, W. Geld : philosophische, literaturwissenschaftliche und ökonomische Perspektiven. Basel: Schwabe, 209-226.

Gutzwiller, Florian; Schwenkglenks, Matthias; Gutzwiller, Felix; Biller-Andorno, Nikola (2012). Szenario einer künftigen Nutzenbewertung medizinischer Leistungen in der Schweiz. In: Swiss Public Health Conference, Lausanne, 30 August 2012 - 31 August 2012.

Kasenda, Benjamin; von Elm, Erik B; You, John; Blümle, Anette; Tomonaga, Yuki; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg; Stegert, Mihaela; Tikkinen, Kari Ao; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail; Mertz, Dominik; Akl, Elie A; Bassler, Dirk; Busse, Jason; Ferreira-González, Ignacio; Lamontagne, Francois; Nordmann, Alain; Rosenthal, Rachel; Schandelmaier, Stefan; Sun, Xin; Vandvik, Per O; Johnston, Bradley C; Walter, Martin A; Burnand, Bernard; Schwenkglenks, Matthias; Bucher, Heiner C; Guyatt, Gordon H; Briel, Matthias (2012). Learning from Failure - Rationale and Design for a Study about Discontinuation of Randomized Trials (DISCO study). BMC Medical Research Methodology, 12:131.

Schwenkglenks, Matthias; Toward, Toby J; Plent, Stephanie; Szucs, Thomas D; Blackman, Daniel J; Baumbach, Andreas (2012). Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction. Heart (British Cardiac Society), 98(7):544-551.

Matter-Walstra, Klazien; Joerger, Markus; Kühnel, Ursula; Szucs, Thomas D; Pestalozzi, Bernhard; Schwenkglenks, Matthias (2012). Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the Swiss health care system. Value in Health, 15(1):65-71.

Gutzwiller, Florian S; Schwenkglenks, Matthias; Blank, Patricia R; Braunhofer, Peter G; Mori, Claudio; Szucs, Thomas D; Ponikowski, Piotr; Anker, Stefan D (2012). Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. European Journal of Heart Failure, 14(7):782-790.

Gutzwiller, Florian; Biller-Andorno, Nikola; Harnacke, Caroline; Bollhalder, Lea; Szucs, Thomas D; Gutzwiller, Felix; Schwenkglenks, Matthias (2012). Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und ihre ethischen Implikationen. Gesundheits- und Sozialpolitik, 66(2):30-36.

Gutzwiller, Florian; Biller-Andorno, Nikola; Harnacke, Caroline; Bollhalder, Lea; Szucs, Thomas D; Gutzwiller, Felix; Schwenkglenks, Matthias (2012). Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und ihre ethischen Implikationen. Bern: Akademien der Wissenschaften Schweiz.

Blank, Patricia; Schwenkglenks, Matthias; Szucs, Thomas D (2012). The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Human Vaccines & Immunotherapeutics, 8(3):328-335.

Salar, Antonio; Haioun, Corinne; Rossi, Francesca G; Duehrsen, Ulrich; Pettengell, Ruth; Johnsen, Hans E; Jaeger, Ulrich; Verhoef, Gregor; Schwenkglenks, Matthias; Bacon, Pamela; Bendall, Kate; Lugtenburg, Pieternella J (2012). The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practice. Leukemia Research, 36(5):548-553.

Tomonaga, Yuki; Gutzwiller, Felix; Lüscher, Thomas F; Riesen, Walter F; Hug, Markus; Diemand, Albert; Schwenkglenks, Matthias; Szucs, Thomas D (2011). Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care:a cluster-randomised controlled trial. BMC Family Practice, 12:12.

Szucs, Thomas D; Schwenkglenks, Matthias; Cathomas, G; Geschwindner, H; Gutzwiller, Felix (2004). Früherfassung des Bronchuskarzinoms – Chancen und Risiken. Schweizerische Ärztezeitung, 85(16):840-843.

This list was generated on Fri Jul 28 11:26:17 2017 CEST.